Nitric Oxide Metabolites, Leukocyte Activation Markers and Oxidative Status in Dialyzed Subjects

被引:16
作者
Caimi, G. [1 ]
Carollo, C. [1 ]
Montana, M. [1 ]
Iatrino, R. [1 ]
Bondi, B. [1 ]
Lo Presti, R. [1 ]
机构
[1] Univ Palermo, Dipartimento Med Interna Malattie Cardiovasc & Ne, IT-90127 Palermo, Italy
关键词
Hemodialysis; Oxidative status; Nitric oxide; Elastase; Myeloperoxidase; CHRONIC-RENAL-FAILURE; CHRONIC KIDNEY-DISEASE; MAINTENANCE HEMODIALYSIS-PATIENTS; CARDIOVASCULAR-DISEASE; SERUM MALONDIALDEHYDE; ANTIOXIDANT CAPACITY; NEUTROPHIL ELASTASE; LIPID-PEROXIDATION; PLASMA-LEVELS; VITAMIN-E;
D O I
10.1159/000193218
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Our purpose was to evaluate, in a group of 42 end-stage renal disease patients who regularly undergo hemodialysis, some indexes of leukocyte activation, nitric oxide metabolites (NOx) and other parameters that reflect the oxidative stress before and after a standard hemodialysis session. Methods: Elastase and myeloperoxidase (MPO) were determined by means of ELISA. The NO production was evaluated by a micromethod which measures the concentration of NOx. The oxidation of polyunsaturated fatty acids was evaluated in plasma by detection of thiobarbituric acid-reactive substances (TBARS). Total antioxidant status (TAS) was obtained using spectrophotometry. Results: At baseline, we observed an increase of elastase, NOx, TBARS and TAS, without any variation of MPO. After the dialysis session, we found an increase in elastase and MPO, a decrease in NOx and TAS and no variation in TBARS. No modification occurred after subdividing the patients in two subgroups. Conclusions: Our data confirm the involvement of leukocytes and oxidative stress in hemodialysis patients. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:194 / 198
页数:5
相关论文
共 46 条
[41]   Statin treatment and diabetes affect myeloperoxidase activity in maintenance hemodialysis patients [J].
Stenvinkel, Peter ;
Rodriguez-Ayala, Ernesto ;
Massy, Ziad A. ;
Qureshi, Abdul Rashid ;
Barany, Peter ;
Fellstrom, Bengt ;
Heimburger, Olof ;
Lindholm, Bengt ;
Alvestrand, Anders .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 (02) :281-287
[42]   EFFECT OF HEMODIALYSIS ON LIPID-PEROXIDATION AND ANTIOXIDANT SYSTEM IN PATIENTS WITH CHRONIC-RENAL-FAILURE [J].
TOBOREK, M ;
WASIK, T ;
DROZDZ, M ;
KLIN, M ;
MAGNERWROBEL, K ;
KOPIECZNAGRZEBIENIAK, E .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1992, 41 (11) :1229-1232
[43]   The influence of the hemodialysis treatment time under oxidative stress biomarkers in chronic renal failure patients [J].
Valentini, Juliana ;
Grotto, Denise ;
Paniz, Clovis ;
Roehrs, Miguel ;
Burg, Geni ;
Garcia, Solange C. .
BIOMEDICINE & PHARMACOTHERAPY, 2008, 62 (06) :378-382
[44]   The role of NF-κB in the regulation of cell stress responses [J].
Wang, TL ;
Zhang, X ;
Li, JJ .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2002, 2 (11) :1509-1520
[45]   AOPP-induced activation of human neutrophil and monocyte oxidative metabolism:: A potential target for N-acetylcysteine treatment in dialysis patients [J].
Witko-Sarsat, W ;
Gausson, V ;
Nguyen, AT ;
Touam, M ;
Drüeke, T ;
Santangelo, F ;
Descamps-Latscha, B .
KIDNEY INTERNATIONAL, 2003, 64 (01) :82-91
[46]   Red blood cell and plasma glutathione peroxidase activities and selenium concentration in patients with chronic kidney disease:: A review [J].
Zachara, Bronislaw A. ;
Gromadzinska, Jolanta ;
Wasowicz, Wojciech ;
Zbrog, Zbigniew .
ACTA BIOCHIMICA POLONICA, 2006, 53 (04) :663-677